A detailed history of Vestor Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vestor Capital, LLC holds 45,820 shares of LLY stock, worth $34.3 Million. This represents 3.19% of its overall portfolio holdings.

Number of Shares
45,820
Previous 57,800 20.73%
Holding current value
$34.3 Million
Previous $52.3 Million 22.43%
% of portfolio
3.19%
Previous 4.22%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$772.14 - $960.02 $9.25 Million - $11.5 Million
-11,980 Reduced 20.73%
45,820 $40.6 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $12.7 Million - $15.9 Million
17,503 Added 43.43%
57,800 $52.3 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $2.58 Million - $3.46 Million
4,365 Added 12.15%
40,297 $31.4 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $490,002 - $577,648
933 Added 2.67%
35,932 $20.9 Million
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $132,583 - $182,786
-305 Reduced 0.86%
34,999 $18.8 Million
Q2 2023

Aug 21, 2023

BUY
$350.74 - $468.98 $10.2 Million - $13.6 Million
29,055 Added 464.95%
35,304 $16.6 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $5.74 Million - $7.68 Million
-16,373 Reduced 72.38%
6,249 $2.14 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $5.6 Million - $6.57 Million
-18,021 Reduced 44.34%
22,622 $7.77 Million
Q1 2023

Apr 26, 2023

SELL
$310.63 - $364.82 $4.76 Million - $5.59 Million
-15,315 Reduced 27.37%
40,643 $3.74 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $4.4 Million - $5.13 Million
13,689 Added 32.39%
55,958 $20.5 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $6.95 Million - $7.92 Million
-23,448 Reduced 35.68%
42,269 $13.7 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $88,357 - $103,744
-317 Reduced 0.48%
65,717 $21.3 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $2.65 Million - $3.29 Million
11,283 Added 20.61%
66,034 $18.9 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $35,751 - $44,367
159 Added 0.29%
54,751 $15.1 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $25,262 - $31,088
-114 Reduced 0.21%
54,592 $12.6 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $470,513 - $608,605
-2,606 Reduced 4.55%
54,706 $12.6 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $95,141 - $123,164
579 Added 1.02%
57,312 $10.7 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $3,131 - $4,143
24 Added 0.04%
56,733 $9.58 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $1.38 Million - $1.6 Million
9,440 Added 19.97%
56,709 $8.39 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $5.54 Million - $6.86 Million
46,558 Added 6548.24%
47,269 $6.56 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $23,950 - $29,664
-224 Reduced 23.96%
711 $93,000
Q3 2019

Nov 20, 2019

BUY
$106.79 - $116.16 $99,848 - $108,609
935 New
935 $104,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vestor Capital, LLC Portfolio

Follow Vestor Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.